These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10160205)

  • 1. Consensus on surfactant and inhaled nitric oxide for ARDS.
    Gadek JE
    J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
    Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
    N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
    Weg JG; Balk RA; Tharratt RS; Jenkinson SG; Shah JB; Zaccardelli D; Horton J; Pattishall EN
    JAMA; 1994 Nov; 272(18):1433-8. PubMed ID: 7933425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
    Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
    Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of ARDS with two doses of synthetic surfactant.
    Heikinheimo M; Hynynen M; Rautiainen P; Andersson S; Hallman M; Kukkonen S
    Chest; 1994 Apr; 105(4):1263-4. PubMed ID: 8162762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for lung failure using nitric oxide inhalation and surfactant replacement.
    Strüber M; Brandt M; Cremer J; Harringer W; Hirt SW; Haverich A
    Ann Thorac Surg; 1996 May; 61(5):1543-5. PubMed ID: 8633984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
    Doig C
    JAMA; 1995 Apr; 273(16):1259-60. PubMed ID: 7715036
    [No Abstract]   [Full Text] [Related]  

  • 9. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.
    Perez-Benavides F; Riff E; Franks C
    Pediatr Emerg Care; 1995 Jun; 11(3):153-5. PubMed ID: 7651868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
    Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
    Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
    Kozlov IA; Poptsov VN
    Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
    Balaraman V; Meister J; Ku TL; Sood SL; Tam E; Killeen J; Uyehara CF; Egan E; Easa D
    Am J Respir Crit Care Med; 1998 Jul; 158(1):12-7. PubMed ID: 9655700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing surfactant products.
    Prevost RR
    Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
    [No Abstract]   [Full Text] [Related]  

  • 14. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acute respiratory distress syndrome.
    Matthay MA
    N Engl J Med; 1996 May; 334(22):1469-70. PubMed ID: 8618587
    [No Abstract]   [Full Text] [Related]  

  • 17. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 18. Surfactant replacement therapy: issues related to currently available preparations.
    Bose G
    Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367
    [No Abstract]   [Full Text] [Related]  

  • 19. Surfactant: current and potential therapeutic application in infants and adults.
    Lewis J; Veldhuizen RA
    J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.